注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Gritstone bio Inc是一家生物技術公司。該公司通過疫苗載體、自擴增mRNA (samRNA)和黑猩猩腺病毒(ChAd)發現、開發、製造和提供下一代癌症和傳染病免疫治療候選藥物。其處於臨床階段開發的兩個腫瘤學項目是 GRANITE(基於新抗原的個體化免疫療法)和SLATE(一種現成的基於新抗原的共享免疫療法)。該公司擁有一個傳染病管道,其中包括兩個處於臨床階段開發的項目:CORAL,一個可能具有泛冠狀病毒潛力的第二代COVID-19疫苗項目,以防止未來的冠狀病毒大流行,以及一種 HIV 治療/治愈疫苗 與 Gilead Sciences, Inc. 合作的候選產品包括GRT-C907 (ChAd)/R908 (samRNA)、GRT-C909 (ChAd)/R910 (samRNA)、GRT-C909 (ChAd)/R910 (samRNA) )、GRT-R914 (samRNA)、GRT-R912 (samRNA)和GRT-R918 (samRNA)。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Elaine V. Jones | 66 | 2019 | Independent Chairman of the Board |
Andrew R. Allen | 54 | 2015 | Co-Founder, President, CEO & Director |
Jean-Charles Soria | 50 | 2020 | Member of Scientific Advisory Board |
Steve Edward Krognes | 54 | 2018 | Independent Director |
Lawrence Corey | 76 | 2022 | Independent Director |
Eugene Zhukovsky | 64 | 2019 | Member of Scientific Advisory Board |
Naiyer A. Rizvi | 59 | 2016 | Independent Director & Member of Scientific Advisory Board |
Graham Lord | - | 2017 | Member of Scientific Advisory Board |
Alessandro Sette | - | 2017 | Member of Scientific Advisory Board |
James L. Gulley | - | 2017 | Member of Scientific Advisory Board |
Clare Fisher | 50 | 2022 | Independent Director |
Timothy A. Chan | - | 2017 | Member of Scientific Advisory Board |
Shefali Agarwal | 50 | 2021 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核